Skip to main content
LLY logo

Eli Lilly and Company

LLYNYSEHealthcareDrug Manufacturers - General

$1,288.30Today:- (-)1Y +59.15%

As of Oct 28, 2026 close

Market cap
$1.15T
P/E (TTM)
43.10
Forward P/E
22.66
Dividend yield
0.51%
52-week range
$793.82$1,311.75
Volume (live)
-
Avg. volume (3M)
2.33M

Eli Lilly and Company (LLY) Financial Ratios

For fiscal 2025 (fiscal year ended Dec 31, 2025), Eli Lilly and Company had a P/E ratio of 46.62 (down from 65.64), return on equity of 101.2% (up from 84.3%), debt-to-equity of 1.65 (down from 2.44) and a current ratio of 1.58 (up from 1.15). A current ratio of 1.58 means current assets exceed current liabilities. Its dividend yield was 0.56% with a payout ratio of 26.1%.

Eli Lilly and Company Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio46.6265.64100.0455.6644.8624.71
Forward P/E34.3335.1353.3746.2731.7720.18
P/S Ratio14.7615.4315.3612.188.846.24
P/B Ratio36.2648.7148.2632.2627.3526.28
Price/Tangible Book68.17297.57----
Price/FCF107.25184.88661.9060.6541.3529.94
Price/OCF57.2378.83123.6445.8334.0023.55
PEG Ratio1.070.932.512.542.201.57
Enterprise Value Ratios
EV/Revenue15.2616.0415.8712.639.276.75
EV/EBITDA31.3838.4145.6935.4126.7219.40
EV/EBIT33.4942.3952.4441.6531.7222.96
EV/FCF110.86192.12683.7062.8843.3332.39
Profitability & Returns
Return on Equity (ROE)101.16%84.26%48.43%62.67%74.52%145.32%
Return on Assets (ROA)19.42%14.92%11.37%11.00%10.84%10.49%
Return on Invested Capital (ROIC)43.74%35.54%27.99%33.88%36.42%35.65%
Return on Capital Employed (ROCE)38.40%33.90%28.10%26.70%24.50%21.10%
Leverage & Solvency Ratios
Debt/Equity1.652.442.441.521.852.90
Debt/EBITDA1.381.832.201.611.721.98
Debt/FCF4.899.2533.412.862.793.30
Liquidity Ratios
Current Ratio1.581.150.941.051.231.40
Quick Ratio0.780.570.520.630.800.85
Efficiency Ratios
Asset Turnover0.680.630.600.580.590.57
Inventory Turnover1.041.261.411.621.771.53
Yield & Distribution Ratios
Earnings Yield2.15%1.52%1.00%1.80%2.23%4.05%
FCF Yield0.93%0.54%0.15%1.65%2.42%3.34%
Dividend Yield0.56%0.67%0.78%1.02%1.23%1.85%
Payout Ratio26.09%44.19%77.65%56.62%55.30%43.38%
Buyback Yield0.53%-0.09%0.15%0.78%0.09%2.48%
Total Return1.09%0.58%0.92%1.79%1.32%4.32%

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Eli Lilly and Company Financial Ratios

What is Eli Lilly and Company's P/E ratio?

Eli Lilly and Company's P/E ratio was 46.62 for fiscal 2025 (period ended Dec 31, 2025). It was 65.64 a year earlier.

What is Eli Lilly and Company's return on equity?

Eli Lilly and Company's return on equity (ROE) was 101.2% for fiscal 2025 (period ended Dec 31, 2025). It was 84.3% a year earlier.

What is Eli Lilly and Company's debt-to-equity ratio?

Eli Lilly and Company's debt-to-equity ratio was 1.65 for fiscal 2025 (period ended Dec 31, 2025). It was 2.44 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition